Medical Device 2018 - The New EU Medical Device Regulation
Date2018-06-21
Deadline2018-06-21
VenueOnline event, USA - United States
KeywordsRegulatory compliance training; Medical Device; Environment
Topics/Call fo Papers
Overview:
Regulation proposals of the European Commission
Background
In 2012, the Commission adopted a package of measures on innovation in health. The package consisted of a Communication and two regulation proposals to revise existing legislation on general medical devices and in vitro diagnostic medical devices. In particular, the Directives on active implantable medical devices (90/385/EEC) and on medical devices (93/42/EEC) are intended to be replaced by a Regulation on medical devices, while the Directive on in-vitro diagnostic medical devices (98/79/EC) is intended to be replaced by a Regulation on the same subject.
The revisions therefore affected all kinds of medical devices including in vitro diagnostic medical devices, from home-use items like sticking plasters, pregnancy tests and contact lenses, to X-ray machines, pacemakers, breast implants, hip replacements and HIV blood tests.
This webinar will look at what to expect when the new regulation is implemented.
Why should you Attend: Because the current Directive will be significantly altered and replaced by a Regulation which is legally binding on all Member States.
Areas Covered in the Session:
The Updated Regulation
Implementation Dates and Transition
Main Changes and Products Affected
Effect on Medical Device Manufacturers
Who Will Benefit:
Clinical Trial Managers
Regulatory Affairs
Medical Officers
Speaker Profile
Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously,She worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH. She teaches regulatory affairs and clinical strategies at the University of Krems, Austria, and is an independent expert to the European Commission. She holds a PhD in thermal process engineering and an MSc in food and biotechnology from the University of Applied Life Sciences in Vienna, Austria; an MSc from King’s College, University of London in food technology; and an MBA from Open University, and has earned the RAC (EU), CQA and is a Chartered manager.
Event link : http://www.compliance4all.com/control/w_product/~p...
Contact Details:
NetZealous LLC, DBA compliance4All
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
Regulation proposals of the European Commission
Background
In 2012, the Commission adopted a package of measures on innovation in health. The package consisted of a Communication and two regulation proposals to revise existing legislation on general medical devices and in vitro diagnostic medical devices. In particular, the Directives on active implantable medical devices (90/385/EEC) and on medical devices (93/42/EEC) are intended to be replaced by a Regulation on medical devices, while the Directive on in-vitro diagnostic medical devices (98/79/EC) is intended to be replaced by a Regulation on the same subject.
The revisions therefore affected all kinds of medical devices including in vitro diagnostic medical devices, from home-use items like sticking plasters, pregnancy tests and contact lenses, to X-ray machines, pacemakers, breast implants, hip replacements and HIV blood tests.
This webinar will look at what to expect when the new regulation is implemented.
Why should you Attend: Because the current Directive will be significantly altered and replaced by a Regulation which is legally binding on all Member States.
Areas Covered in the Session:
The Updated Regulation
Implementation Dates and Transition
Main Changes and Products Affected
Effect on Medical Device Manufacturers
Who Will Benefit:
Clinical Trial Managers
Regulatory Affairs
Medical Officers
Speaker Profile
Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously,She worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH. She teaches regulatory affairs and clinical strategies at the University of Krems, Austria, and is an independent expert to the European Commission. She holds a PhD in thermal process engineering and an MSc in food and biotechnology from the University of Applied Life Sciences in Vienna, Austria; an MSc from King’s College, University of London in food technology; and an MBA from Open University, and has earned the RAC (EU), CQA and is a Chartered manager.
Event link : http://www.compliance4all.com/control/w_product/~p...
Contact Details:
NetZealous LLC, DBA compliance4All
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
Other CFPs
- The New ISO 13485: 2016 and Comparison with 21CFR820 - how to Comply with Both in the same Organization
- 3-Hour Virtual Seminar on Complaint Handling and Management: From Receipt to Trending
- How to Audit Against ICH GCP 2 Addendum to Ensure Compliance
- Secrets to Writing Effective SOPs for Medical Device QMS
- FDA Compliance and Mobile Applications
Last modified: 2018-05-17 19:02:07